跳至主要内容
临床试验/NCT00562094
NCT00562094已完成不适用

Pantoprazole for the Treatment of GERD Associated Symptoms Focusing on Sleep Disorders.

Nycomed1 个研究点 分布在 1 个国家目标入组 8,616 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Nycomed
入组人数
8,616
试验地点
1
主要终点
Assessment of the Severity of Sleep Disturbances

研究概览

简要总结

The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep disorders.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Pantoprazole

干预措施: Pantoprazole (Drug)

结局指标

主要结局

Assessment of the Severity of Sleep Disturbances

时间窗: first and last visit (after a median of 18 days)

Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe

Assessment of Change of Quality of Sleep During Therapy With Pantoprazole

时间窗: last visit (after a median of 18 days)

Physician's assessment on a scale with * considerably improved * improved * unchanged

次要结局

  • Assessment of the Severity of Heartburn(first and last visit (after a median of 18 days))
  • Assessment of the Severity of Eructation/Acid Eructation(first and last visit (after a median of 18 days))
  • Assessment of the Severity of Epigastric Complaints/Epigastric Pain(first and last visit (after a median of 18 days))
  • Assessment of the Severity of Sensation of Fullness/Abdominal Distension(first and last visit (after a median of 18 days))
  • Assessment of the Efficacy of Pantoprazole at Final Visit(last visit (after a median of 18 days))
  • Assessment of the Tolerability of Pantoprazole at Final Visit(last visit (after a median of 18 days))

研究者

发起方
Nycomed
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验